Look for CRISPR/Cas9 to Treat Eye Diseases First, Scientists Say

Feb 04, 2016

|

This is the fourth article in an in-depth series on the impact of CRISPR/Cas9 genome editing technology on basic and clinical research, the biotechnology industry, and the world at large. The first installment, on the development of the CRISPR toolkit, can be found here.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

PLOS Papers Describe Preconception Carrier Screening, Bacterial Virulence Features, More

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Sharing the Clinical Data

Canadian regulators are beginning to share information from new drug studies, Undark reports.

And Now the Environment's Role

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Possibly Heart-Stopping

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.

Featured White Papers

Efficient High-Throughput SNP Discovery and Genotyping using Normalized Genotyping-by-Sequencing

Ultrasensitive Digital Immunoassay for PSA by Single Molecule Array Simoa Technology in Prostatectomy Patients

RNAGEM - mRNA Profiles as Close to Biological Reality as Possible

Application Note: How to Pipette PCR Master Mix for Increased Accuracy in qPCR Results

Oct

23

Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.

Menu